CDK
Les inhibiteurs des kinases dépendantes des cyclines (CDK) sont des composés qui bloquent l'activité des CDK, un groupe de kinases protéiques qui régulent le cycle cellulaire, la transcription et d'autres processus cellulaires. Les CDK sont activées par leur liaison aux cyclines, et leur activité est cruciale pour la progression des cellules à travers les différentes phases du cycle cellulaire. Inhiber les CDK peut arrêter la division cellulaire, entraînant un arrêt du cycle cellulaire et l'apoptose, en particulier dans les cellules cancéreuses où les CDK sont souvent dysrégulées. Les inhibiteurs de CDK sont largement utilisés dans la recherche sur le cancer et ont un potentiel thérapeutique dans le traitement de divers cancers. Chez CymitQuimica, nous offrons une sélection complète d'inhibiteurs de CDK de haute qualité pour soutenir vos recherches sur le contrôle du cycle cellulaire, le cancer et le développement thérapeutique.
548 produits trouvés pour "CDK"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
LRRK2 inhibitor 1
CAS :LRRK2 inhibitor 1 is a selective and potent LRRK2 inhibitor with an IC50 of 13 nM.LRRK2 inhibitor 1 inhibits DCLK1 kinase with an IC50 value of 2.61 nM.Formule :C20H23N5O4Degré de pureté :99.98%Couleur et forme :SolidMasse moléculaire :397.43Ref: TM-T11878
1mg71,00€2mg92,00€5mg152,00€1mL*10mM (DMSO)167,00€10mg250,00€25mg528,00€50mg893,00€100mg1.414,00€CDK7-IN-21
CAS :CDK7-IN-21 (compound A22) is a potent CDK7 inhibitor [1] .Formule :C33H36FN9O2Couleur et forme :SolidMasse moléculaire :609.7dCeMM3
CAS :dCeMM3 is a glue degrader that induces ubiquitination and degradation of cyclin K by promoting CDK12-cyclin K interaction with CRL4B ligase.
Formule :C14H11ClN4OSDegré de pureté :98.48% - 99.41%Couleur et forme :SolidMasse moléculaire :318.78WAY-322243
CAS :WAY-322243 has antibacterial and anti-inflammatory activity and has an inhibitory effect on CLK-1, which can be used to study Alzheimer's disease.Formule :C18H18N2O2SDegré de pureté :99.88%Couleur et forme :SoildMasse moléculaire :326.41Cdk2/Cyclin Inhibitory Peptide I
CDK2, a Ser/Thr kinase, is akin to yeast cdc28 and human Cdk1, crucial for cell division.Formule :C111H196N48O23Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2571.05CDK4/6-IN-5
CAS :CDK4/6-IN-5 inhibits CDK4/6; Ki: 0.2 nM (CDK4/D1) & 4.4 nM (CDK6/D3). (WO2019207463A1, A93)Formule :C22H28ClFN6O4SCouleur et forme :SolidMasse moléculaire :527.01XY028-133
CAS :XY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.Formule :C53H67N11O7SDegré de pureté :97.11%Couleur et forme :SolidMasse moléculaire :1002.23Ref: TM-T13361
1mg110,00€5mg268,00€10mg467,00€1mL*10mM (DMSO)517,00€25mg802,00€50mg1.414,00€100mg2.457,00€CDK7-IN-7
CAS :CDK7-IN-7: Selective CDK7 inhibitor, IC50 < 50 nM (Patent CN112661745A).Formule :C20H20BrF3N6O2Couleur et forme :SolidMasse moléculaire :513.319PROTAC CDK9 degrader-11
CAS :PROTAC CDK9 degrader-11 (Compound C3) is an orally active PROTAC CDK9 degrader with a DC50 of 1.09 nM. This compound exhibits cytotoxicity in small cell lung cancer (SCLC) cells, with IC50 values in the nanomolar range. It induces cell cycle arrest at the G0/G1 phase and inhibits cell invasion in DMS114 and DMS53 cells. In addition, PROTAC CDK9 degrader-11 shows antitumor activity in an NCI-H446 xenograft mouse model. (Pink: ligand for target protein CDK9 ligand 3; Black: linker; Blue: ligand for E3 ligase Cereblon E3 ligase Ligand 56)Formule :C39H48Cl2N10O5Couleur et forme :SolidMasse moléculaire :807.768IV-361
CAS :IV-361, an orally active and selective CDK7 inhibitor with a Ki value of less than or equal to 50 nM, demonstrates potent anti-cancer activity (US20190256531A1Formule :C23H32FN5O2SiCouleur et forme :SolidMasse moléculaire :457.625CDK8-IN-12
CAS :CDK8-IN-12: selective CDK8 inhibitor (Ki 14 nM), oral anticancer, blocks GSK-3α/β, PCK-θ, halts MV4-11 cell growth.Formule :C21H20ClN3O2Degré de pureté :98.55% - 99.22%Couleur et forme :SoildMasse moléculaire :381.86Ref: TM-T72048
1mg52,00€5mg101,00€1mL*10mM (DMSO)116,00€10mg150,00€25mg250,00€50mg363,00€100mg509,00€200mg695,00€Multi-target kinase inhibitor 2
Compound 5K (Multi-target kinase inhibitor 2) is a multi-targeted kinase inhibitor demonstrating activity against EGFR, Her2, VEGFR2, and CDK2 with IC50 valuesDegré de pureté :98%Couleur et forme :Odour SolidTMX-2039
CAS :TMX-2039 is a pan-CDK inhibitor that targets cell cycle CDKs (CDK1, CDK2, CDK4, CDK5, and CDK6) and transcription CDKs (CDK7 and CDK9), with IC50 values of 2.6, 1.0, 52.1, 0.5, 35.0, 32.5, and 25 nM, respectively. It serves as a ligand for the target protein in PROTAC applications.Formule :C17H20BrFN6O3SCouleur et forme :SolidMasse moléculaire :487.347CDK2/PIM1-IN-1
CDK2/PIM1-IN-1 is an inhibitor of the kinases CDK2 (IC50: 0.27 μM) and PIM1 (IC50: 0.67 μM). It can induce apoptosis (cell death) and reduce the expression of TNF-α, which promotes tumors. CDK2/PIM1-IN-1 exhibits antitumor activity.Couleur et forme :Odour SolidCDK8/19-IN-3
CDK8/19-IN-3 (compound 3-7) is a potent and selective inhibitor of CDK8 and CDK19. It can increase IL-10 levels and has potential for research in inflammatory bowel disease (IBD).Formule :C20H23FN6O2Couleur et forme :SolidMasse moléculaire :398.434CDK12-Cyclin K Ligand-Linker Conjugates 1
CDK12-Cyclin K Ligand-Linker Conjugates 1 is a Target Protein Ligand-Linker Conjugate that includes a CDK12-Cyclin K ligand and a PROTAC linker, which can recruit E3 ligase. CDK12-Cyclin K Ligand-Linker Conjugates 1 is applicable for the synthesis of PROTACPP-C8.Couleur et forme :Odour SolidYJ9069
YJ9069 is a selective CDK12/CDK13P ROTAC degrader with an IC50 of 22.22 nM in VCaP cells. Rapid degradation of CDK12/13 by this compound triggers transcription elongation defects dependent on gene length, leading to DNA damage and cell cycle arrest. YJ9069 effectively inhibits the proliferation of prostate cancer cell subpopulations and significantly suppresses prostate tumor growth in vivo.Formule :C46H46N10O7Couleur et forme :SolidMasse moléculaire :850.92BSJ-04-132
Selective Cdk4 degrader. Degrades Cdk4 in Molt-4 cells, with no effect on Cdk6 levels. Displays cereblon-dependent degradation.Couleur et forme :LiquidCPD-39
CAS :CPD-39 is an efficacious and orally active bifunctional PROTAC degrader targeting both CCND1 and CDK4. It exhibits antiproliferative effects.Formule :C46H57N15O4Couleur et forme :SolidMasse moléculaire :884.04CDK7-IN-6
CAS :CDK7-IN-6, a potent CDK7 inhibitor (IC50 ≤100 nM), from WO2019197549 A1, is >200x selective over CDK1/2/5, promising for cancer research.Formule :C26H34ClN9OCouleur et forme :SolidMasse moléculaire :524.07CDK-IN-13
CDK-IN-13 (compound 32E) is a potent and selective inhibitor of CDK12/cyclin K, exhibiting an IC50 of 3 nM. Additionally, CDK-IN-13 suppresses the growth of HER2-positive breast cancer cell lines.Formule :C23H27N7O3Masse moléculaire :449.21754CDK7-IN-2 hydrochloride hydrate
CAS :CDK7-IN-2 HCl hydrate is a potent, specific CDK7 enzyme inhibitor with significant anti-cancer effects.Formule :C26H42ClN7O4Couleur et forme :SolidMasse moléculaire :552.12CDK12-IN-2
CAS :CDK12-IN-2 selectively inhibits CDK12 (IC50: 52 nM) with minimal effect on CDK2, CDK7, and CDK9, useful for CDK12 research.
Formule :C32H32N6O2Degré de pureté :99.31%Couleur et forme :SolidMasse moléculaire :532.64FDA-Approved Kinase Inhibitor Library
A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.
Couleur et forme :LiquidKinase Inhibitor Library
A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;Couleur et forme :Odour SolidRef: TM-L1600
1mgÀ demander30μL*10mM (DMSO)À demander50μL*10mM (DMSO)À demander100μL*10mM (DMSO)À demander250μL*10mM (DMSO)À demanderEciruciclib
CAS :Eciruciclib is an inhibitor of CDK with antitumor properties.Formule :C27H33FN8Degré de pureté :99.73%Couleur et forme :SolidMasse moléculaire :488.6CDK2/4-IN-1
CDK2/4-IN-1 (compound B-4a) serves as both a CDK2/4 inhibitor and a microtubule polymerization inhibitor, making it useful in cancer research.Couleur et forme :Odour SolidCDK1-IN-2
CAS :CDK1-IN-2 (cdk1 inhibitor 2) is a CDK1 inhibitor with IC50 of 5.8 μM.Formule :C17H11ClN2ODegré de pureté :98.53%Couleur et forme :SoildMasse moléculaire :294.73Ref: TM-T64373
1mg50,00€1mL*10mM (DMSO)103,00€5mg107,00€10mg170,00€25mg354,00€50mg567,00€100mg810,00€500mg1.644,00€Olomoucine
CAS :Olomoucine hinders Cdk2, Cdc2, CDK5, ERK1, regulates the cell cycle, and fights melanoma; IC50s: 3-25 µM.
Formule :C15H18N6ODegré de pureté :99.77%Couleur et forme :White Crystalline PowderMasse moléculaire :298.34TL12-186
CAS :TL12-186 is a Cereblon-dependent kinase degrader that degrades CDK, BTK, FLT3, Aurora and other kinases.TL12-186 inhibits CDK2/cyclin A and CDK9/cyclin T1 withFormule :C44H51ClN10O9SDegré de pureté :98.2%Couleur et forme :SolidMasse moléculaire :931.46Ref: TM-T34888
1mg69,00€2mg89,00€5mg147,00€10mg224,00€1mL*10mM (DMSO)245,00€25mg358,00€50mg512,00€100mg707,00€200mg973,00€YX-2-107
CAS :YX-2-107: CDK6-degrading PROTAC, IC50 of 4.4 nM, hinders RB phosphorylation/FOXM1, counters Ph+ ALL growth in rats, targets Ph+ ALL prophylaxis/treatment.Formule :C45H51N11O9Degré de pureté :98.09% - 99.148%Couleur et forme :SolidMasse moléculaire :889.95CDK2-IN-7
CAS :CDK2-IN-7 is a CDK2 inhibitor for treating cancer ( IC 50 < 50 nM).Formule :C24H30N6O4SCouleur et forme :SolidMasse moléculaire :498.6Cell Cycle Compound Library
A unique collection of xnum cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
Couleur et forme :Odour SolidCDK6/9-IN-1
CAS :CDK6/9-IN-1, an oral dual inhibitor of CDK6/9, has IC50s of 40.5nM (CDK6) and 39.5nM (CDK9).Formule :C22H25ClN8OCouleur et forme :SolidMasse moléculaire :452.95CDK12/13-IN-2
CDK12/13-IN-2 (Compound 24) is a covalent inhibitor of CDK12 and CDK13, exhibiting IC50 values of 15.5 nM and 12.2 nM, respectively. It effectively inhibits the proliferation of breast cancer cells and can be utilized in the research of triple-negative breast cancer.Formule :C24H22FN7O2Couleur et forme :SolidMasse moléculaire :459.48CDK-IN-12
CAS :CDK-IN-12 (Example 20), a CDK inhibitor, effectively inhibits CDK4/6, demonstrating IC50 values below 20 nM [1].Formule :C26H29FN6OSCouleur et forme :SolidMasse moléculaire :492.61JH-XVI-178
CAS :JH-XVI-178: potent CDK8/19 inhibitor with good pharmacokinetics, low clearance, moderate oral bioavailability.Formule :C22H22ClN7OCouleur et forme :SolidMasse moléculaire :435.92Leucettine L41
CAS :Leucettine L41 (LeucettineL41) is an inhibitor of DYRKs/CLKs, preferentially targeting DYRK1A, and inhibits DYRK2.Formule :C17H13N3O3Degré de pureté :99.08%Couleur et forme :SolidMasse moléculaire :307.3CDK9-IN-35
CDK9-IN-35 (compound 10j) acts as an inhibitor of CDK9/CyclinT1, exhibiting an IC50 of 10.2 nM. It also shows an IC50 of 20 nM against the HCT-116 cell line.Formule :C26H24ClFN4O4SCouleur et forme :SolidMasse moléculaire :543.01PROTAC CDK9 degrader 4
CAS :PROTAC CDK9 degrader 4 is a CDK9 degrader that targets transcriptional regulation and has potential anticancer activity.Formule :C43H56N10O5Couleur et forme :SolidMasse moléculaire :792.97CDK-IN-15
CAS :CDK-IN-15 (Compound 456) is an effective inhibitor of Cyclin A, exhibiting an IC50 value of 0.14 μM.Formule :C45H63Cl2F4N7O8Couleur et forme :SolidMasse moléculaire :976.92CP-10
CAS :CP-10, a selective PROTAC, degrades CDK6 (DC50: 2.1 nM) and inhibits hematopoietic cancers, including multiple myeloma.Formule :C44H49N13O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :871.94Ref: TM-T13627
100mgÀ demander200mgÀ demander5mg655,00€10mg897,00€1mL*10mM (DMSO)952,00€50mg1.972,00€TMX-2138
CAS :TMX-2138 is a CDKs PROTAC degrader, with IC50 values of 8.7 nM for CDK1/cyclinB, 10.9 nM for CDK2/cyclinA, 7.0 nM for CDK5/p25, and 25.7 nM for CDK9/cyclinT1. It enhances the ubiquitination and degradation of CDKs and is utilized for ovarian cancer research.Formule :C40H43BrFN9O11SCouleur et forme :SolidMasse moléculaire :956.791CDK9 degrader-1
CDK9degrader-1 is a selective CDK9 degrader (DC50: 0.4073 µM). It recruits ATG101 to initiate the autophagy-lysosome pathway and forms autophagosomes by recruiting LC3, which then fuse with lysosomes to degrade CDK9 and its partner protein, Cyclin T1 (DC50: 1.215 µM). CDK9degrader-1 induces caspase 3-mediated apoptosis and exhibits antitumor activity in a mouse HCT116 xenograft model.Formule :C32H34Cl2N6O4Couleur et forme :SolidMasse moléculaire :637.56CDK7/9-IN-1
CAS :CDK7/9-IN-1 inhibits CDK7/9 with IC50: 0.0656 μM (no pre-incubation), 0.00574 μM (3h pre-inc.), and CDK9: 2.14 μM (3h pre-inc.) for cancer research.Formule :C24H32F3N5O2Couleur et forme :SolidMasse moléculaire :479.548Cdk2/Cyclin Inhibitory Peptide II
CAS :Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, demonstrates dose-dependent cytotoxic effects on U2OS osteosarcoma cells [1].Formule :C110H200N48O25Couleur et forme :SolidMasse moléculaire :2595.07SNX7
CAS :SNX7 (WAY-323879) inhibits CDKI pathway; useful for studying aging and related diseases.Formule :C15H14N2ODegré de pureté :99.96%Couleur et forme :SolidMasse moléculaire :238.28PROTAC CDK9 degrader-9
PROTAC CDK9 degrader-9 (compound 29) is a highly efficient, selective degrader of CDK9 based on PROTAC technology. It is utilized in cancer research.Formule :C42H51FN12O6Couleur et forme :SolidMasse moléculaire :838.93BSJ-03-204
CAS :BSJ-03-204 is a selective Cdk4/6 degrader.Formule :C43H48N10O8Couleur et forme :SolidMasse moléculaire :832.9JH-XI-10-02
CAS :JH-XI-10-02 selectively degrades CDK8 (IC50: 159 nM) through proteasome, sparing CDK8 mRNA and CDK19.Formule :C53H69N5O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :920.161CDK12-IN-6
CAS :CDK12-IN-6, a pyrazolotriazine, strongly inhibits CDK12 (IC50 1.19 μM at 2 mM ATP), but not CDK2/Cyclin E or CDK9/Cyclin T1 (both IC50 >20 μM).Formule :C20H21F2N9Couleur et forme :SolidMasse moléculaire :425.448[pSer2, pSer5, pSer7]-CTD TFA
Substrate '[pSer2, pSer5, pSer7]-CTD (TFA)' for CDK7 phosphorylates RNA Pol II CTD at ser2, 5, 7.Formule :C98H138F3N21O39Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2291.25PP-C8
PP-C8: PROTAC CDK12-Cyclin K degrader with DC50s 416/412 nM; synergizes with PARP inhibitor against TNBC.Formule :C43H51FN12O7Couleur et forme :SolidMasse moléculaire :866.94NCT02
CAS :NCT02 degrades cyclin K, leading to CCNK and CDK12 degradation, potentially aiding metastatic CRC research.Formule :C17H16N2O2SCouleur et forme :SolidMasse moléculaire :312.39CDK5-IN-3
CAS :CDK5-IN-3 is a selective and potent CDK5 inhibitor that inhibits CDK5/p25 and CDK2/CycA, and can be used in the study of cancer.Formule :C22H26N4ODegré de pureté :98.21%Couleur et forme :SolidMasse moléculaire :362.47Palbociclib-d8
CAS :Palbociclib-d8 (PD 0332991 D8) is the deuterated form of Palbociclib. Palbociclib is a CDK inhibitor that inhibits CDK4 and CDK6.Formule :C24H21D8N7O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :455.58SB1317
CAS :SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).Formule :C23H24N4ODegré de pureté :99.86%Couleur et forme :SolidMasse moléculaire :372.46TG003
CAS :TG003 is a Clk1/Sty inhibitor that inhibits Clk1 and Clk4, suppresses cancer cell growth, and induces apoptosis.Formule :C13H15NO2SDegré de pureté :99.46%Couleur et forme :SolidMasse moléculaire :249.33Ref: TM-T60367
1mg48,00€5mg92,00€10mg150,00€1mL*10mM (DMSO)167,00€25mg266,00€50mg440,00€100mg530,00€200mg767,00€NU6102
CAS :NU6102 is a CDK2 inhibitor with antitumor activity against CDK1/cyclinB, CDK1/CDK2, CDK4, DYRK1A , PDK1, and ROCKII, and it can be used to study rectal cancer.Formule :C18H22N6O3SDegré de pureté :99.76%Couleur et forme :SolidMasse moléculaire :402.47LDC4297
CAS :LDC4297 (LDC044297) is a potent and selective CDK7 inhibitor.Formule :C23H28N8ODegré de pureté :98.25%Couleur et forme :SolidMasse moléculaire :432.52GP-82996
CAS :GP-82996 (CINK4) inhibits CDK4/6; IC50s: 1.5 μM (CDK4/D1), 5.6 μM (CDK6/D1), 25 μM (Cdk5/p35); triggers U2OS cancer cell apoptosis.Formule :C27H32N6ODegré de pureté :99.94%Couleur et forme :SolidMasse moléculaire :456.58(E/Z)-Zotiraciclib hydrochloride
CAS :(E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride is a potent inhibitor of CDK2, JAK2, and FLT3.Formule :C23H25ClN4OCouleur et forme :SolidMasse moléculaire :408.93Ribociclib hydrochloride
CAS :Ribociclib hydrochloride (LEE011 HCl) is a selective, orally active cyclin-dependent kinase CDK4/6 inhibitor (IC50=10/39 nM) that inhibits proliferation.Formule :C23H31ClN8ODegré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :471Palbociclib hydrochloride
CAS :Palbociclib hydrochloride is the salt form of Palbociclib, a selective and orally available CDK4 and CDK6 inhibitor for breast and hepatocellular carcinoma.Formule :C24H31Cl2N7O2Degré de pureté :99.89%Couleur et forme :SolidMasse moléculaire :520.46FMF-04-159-2
CAS :FMF-04-159-2 is a potent covalent CDK14 & CDK2 inhibito and is able to reduce α-Syn aggregation in neurons, and inhibits TNBC cancer progression.Formule :C28H30Cl3N7O5SDegré de pureté :96.57%Couleur et forme :SolidMasse moléculaire :683.01PROTAC CDK9 Degrader-1
CAS :PROTAC CDK9 Degrader-1 is a selective PROTAC-based CDK9 degrader, composed of a Cereblon ligand and a CDK ligand.Formule :C33H35N5O7Degré de pureté :95.1%Couleur et forme :SolidMasse moléculaire :613.66Ribociclib-d6
CAS :Ribociclib-d6 is a deuterated compound of Ribociclib (LEE011) for isotope tracing.Ribociclib is an orally available CDK4/6 inhibitor with antitumor activity.Formule :C23H30N8OCouleur et forme :SolidMasse moléculaire :440.57CDK9-IN-1
CAS :CDK9-IN-1 is a selective and potent CDK9 inhibitor with antiviral activity used in the study of PRRSV infections.Formule :C26H21N5O4SDegré de pureté :98.52%Couleur et forme :SolidMasse moléculaire :499.54TG-693
CAS :TG-693, Oral CLK1 inhibitor, promotes exon 31 skipping of dystrophin gene, inhibits CLK1 substrate phosphorylation, for Duchenne muscular dystrophy.Formule :C12H9N3Degré de pureté :99.81%Couleur et forme :SolidMasse moléculaire :195.23Dalpiciclib hydrochloride
Dalpiciclib (SHR-6390) HCl is an oral CDK4/6 inhibitor with IC50s of 12.4/9.9 nM, an antitumor for breast and esophageal cancers.Formule :C25H31ClN6O2Couleur et forme :SolidMasse moléculaire :483.011-NM-PP1
CAS :1-NM-PP1 (PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors.Formule :C20H21N5Degré de pureté :98% - 98.93%Couleur et forme :White Cyrstalline SolidMasse moléculaire :331.41Ref: TM-T2153
1mg48,00€2mg63,00€5mg84,00€1mL*10mM (DMSO)90,00€10mg132,00€25mg271,00€50mg505,00€100mg668,00€Atuveciclib
CAS :Atuveciclib Racemate is an oral CDK9 inhibitor with a 13 nM IC50, targeting P-TEFb/CDK9 selectively.Formule :C18H18FN5O2SDegré de pureté :98.8%Couleur et forme :SolidMasse moléculaire :387.43Ref: TM-T10464L
1mg84,00€2mg114,00€5mg192,00€1mL*10mM (DMSO)212,00€10mg313,00€25mg580,00€50mg773,00€100mg1.063,00€DRB
CAS :DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM)
Formule :C12H12Cl2N2O4Degré de pureté :99.46% - 99.83%Couleur et forme :White To Off-White Crystalline SolidMasse moléculaire :319.14PHA-767491 hydrochloride
CAS :PHA-767491 (CAY-10572) is a potent Cdc7/CDK9 inhibitor (IC50: 10/34 nM), selective against GSK3-β, CDK1/2, CDK5, MK2, CHK2, PLK1.Formule :C12H12ClN3ODegré de pureté :99.56% - 99.92%Couleur et forme :SolidMasse moléculaire :249.69Cdk5 Substrate acetate
Cdk5, a serine/threonine kinase active in neurons, phosphorylates proteins like histone H1; its synthetic substrate has a Km of 5 µM.Formule :C55H103N15O14Degré de pureté :96.21%Couleur et forme :SolidMasse moléculaire :1198.5PF-06873600
CAS :PF-06873600: oral CDK inhibitor (CDK2/4/6), Ki 0.09-0.16 nM, potential anticancer drug.Formule :C20H27F2N5O4SDegré de pureté :98.77% - 99.55%Couleur et forme :SolidMasse moléculaire :471.52Ref: TM-T8463
1mg54,00€5mg114,00€1mL*10mM (DMSO)118,00€10mg178,00€25mg334,00€50mg557,00€100mg888,00€200mg1.198,00€AMG 925 HCl
CAS :AMG 925 HCl is a selective and potent dual inhibitor of FLT3 (IC50: 2±1 nM) and CDK4 (IC50: 3±1 nM).Formule :C26H30ClN7O2Couleur et forme :SolidMasse moléculaire :508.02CDK9-IN-30
CAS :CDK9-IN-30 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.Formule :C16H20FNO3Degré de pureté :99.75%Couleur et forme :SolidMasse moléculaire :293.33AZD-5438
CAS :AZD-5438 is an effective inhibitor of CDK, for CDK1(IC50=16 nM), CDK2(IC50=6 nM), CDK9(IC50=20 nM).Formule :C18H21N5O2SDegré de pureté :99.73% - 99.87%Couleur et forme :SolidMasse moléculaire :371.46Flavopiridol hydrochloride
CAS :Flavopiridol hydrochloride (MDL 107826A), an inhibitor of cyclin-dependent kinase, is a synthetic N-methylpiperidinyl chlorophenyl flavone compound.Formule :C21H21Cl2NO5Degré de pureté :98.87% - 99.88%Couleur et forme :SolidMasse moléculaire :438.3AG-494
CAS :AG-494 (Tyrphostin B48) is an inhibitor of epidermal growth factor receptor kinase.Formule :C16H12N2O3Degré de pureté :98.69%Couleur et forme :SolidMasse moléculaire :280.28Seliciclib
CAS :Seliciclib (Roscovitine) is a potent inhibitor of Cdk2/cyclin E, also inhibits Cdk7, Cdk5 and Cdc2. Seliciclib has antitumor effect. Cost-effective, quality assurance.Formule :C19H26N6ODegré de pureté :97.15% - 99.89%Couleur et forme :White To Off-White SolidMasse moléculaire :354.45Bromosporine
CAS :Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.Formule :C17H20N6O4SDegré de pureté :99.65% - 99.79%Couleur et forme :SolidMasse moléculaire :404.44Ref: TM-T6255
1mg44,00€2mg57,00€1mL*10mM (DMSO)92,00€5mg93,00€10mg133,00€25mg260,00€50mg416,00€100mg665,00€200mg888,00€BSJ-03-123
CAS :BSJ-03-123 is a potent, CDK6-selective small-molecule degrader.Formule :C47H56N10O11Degré de pureté :97.78% - 99.38%Couleur et forme :SolidMasse moléculaire :937.01Ref: TM-T5395
1mg87,00€2mg113,00€5mg177,00€10mg259,00€25mg409,00€50mg560,00€100mg800,00€500mg1.611,00€(E/Z)-Zotiraciclib
CAS :(E/Z)-Zotiraciclib ((E/Z)-TG02) inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 nM, respectively.Formule :C23H24N4ODegré de pureté :97.75% - 99.92%Couleur et forme :SolidMasse moléculaire :372.46Ref: TM-T21503
1mg43,00€2mg56,00€1mL*10mM (DMSO)90,00€5mg93,00€10mg113,00€25mg200,00€50mg330,00€100mg480,00€PF-562271 besylate
CAS :PF-562271 besylate: potent, ATP-competitive FAK inhibitor, IC50 1.5 nM, 10x less effective on Pyk2, highly selective vs other kinases.Formule :C21H20F3N7O3S·C6H6O3SDegré de pureté :97.65% - 99.01%Couleur et forme :SolidMasse moléculaire :665.66Ref: TM-T6177
1mg35,00€5mg74,00€1mL*10mM (DMSO)89,00€10mg94,00€25mg138,00€50mg198,00€100mg296,00€200mg427,00€Indirubin-3'-monoxime
CAS :Indirubin-3'-monoxime (Indirubin-3'-oxime) is a potent inhibitor of GSK3β (IC50: 22 nM) and also inhibits CDKs ( (IC50s: 100/180/250 nM for Cdk5/p35, Cdk1/Formule :C16H11N3O2Degré de pureté :99.55%Couleur et forme :Dark Red SolidMasse moléculaire :277.28JSH-150
CAS :JSH-150 is a highly selective CDK9 inhibitor(IC50 : 1 nM).Formule :C24H33ClN6O2SDegré de pureté :99.96% - 99.96%Couleur et forme :SolidMasse moléculaire :505.08THZ1 Hydrochloride
THZ1 Hydrochloride: selective covalent CDK7 inhibitor, IC50 of 3.2 nM; affects CDK12/13 & lowers MYC expression.Formule :C31H29Cl2N7O2Couleur et forme :SolidMasse moléculaire :602.51Dinaciclib
CAS :Dinaciclib (SCH 727965) is a CDK inhibitor that selectively inhibits CDK1, CDK2, CDK5, and CDK9 (IC50 = 3/1/1/4 nM).Formule :C21H28N6O2Degré de pureté :98.21% - 99.75%Couleur et forme :SolidMasse moléculaire :396.49LY3143921
CAS :LY3143921 ((S)-Example 2) is an orally active inhibitor of CDC7 kinase with broad in vitro anticancer activity [1].Formule :C16H12FN5OCouleur et forme :SolidMasse moléculaire :309.37BIO
CAS :7BIO triggers nonapoptotic death, blocks FLT3, DYRK1A/2, Aurora B/C kinases.
Formule :C16H10BrN3O2Degré de pureté :99.67%Couleur et forme :SolidMasse moléculaire :356.17PF-562271
CAS :PF-562271 is an effective ATP-competitive, reversible inhibitor of FAK(IC50=1.5 nM) and Pyk2 kinase(IC50=13 nM).Formule :C21H20F3N7O3SDegré de pureté :97.17% - >99.99%Couleur et forme :SolidMasse moléculaire :507.49BS-181 dihydrochloride
CAS :BS-181 dihydrochloride: Potent CDK7 inhibitor (IC50: 21 nM), less effective on CDK2/5/9, no impact on CDK1/4/6, halts cancer cell growth, triggers apoptosis.Formule :C22H34Cl2N6Couleur et forme :SolidMasse moléculaire :453.46THZ1
CAS :THZ1 (CDK7 inhibitor) is a selective inhibitor of CDK7, binding to the Cys residue located at the outer end of the classical kinase domain. Cost-effective and quality-assured.Formule :C31H28ClN7O2Degré de pureté :97.42% - 99.27%Couleur et forme :SolidMasse moléculaire :566.05PHA-767491
CAS :PHA-767491 (CAY10572) is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.Formule :C12H11N3ODegré de pureté :99.49% - >99.99%Couleur et forme :SolidMasse moléculaire :213.24Ref: TM-T6206
2mg34,00€5mg49,00€1mL*10mM (DMSO)50,00€10mg64,00€25mg92,00€50mg138,00€100mg197,00€200mg295,00€2-Chloropyrazine
CAS :2-Chloropyrazine is used in chemical industry.Formule :C4H3ClN2Degré de pureté :98.98% - 99.89%Couleur et forme :Clear Colorless To Yellowish LiquidMasse moléculaire :114.53RGB-286638 free base
CAS :RGB-286638 free base inhibits CDKs (1-5 nM), weaker on CDK7/6.Formule :C29H35N7O4Degré de pureté :98% - 99.91%Couleur et forme :SolidMasse moléculaire :545.63CKI-7
CAS :CKI-7 is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor.Formule :C11H14Cl3N3O2SDegré de pureté :>99.99%Couleur et forme :SolidMasse moléculaire :358.67Ref: TM-T19913
1mg73,00€5mg128,00€1mL*10mM (DMSO)140,00€10mg185,00€25mg299,00€50mg405,00€100mg545,00€AT7519 Hydrochloride
CAS :AT7519 Hydrochloride (AT7519 HCl) is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9.Formule :C16H18Cl3N5O2Degré de pureté :99.66% - 99.9%Couleur et forme :SolidMasse moléculaire :418.71
